600056 China Meheco Group
- 11.08
- -0.47-4.07%
About China Meheco Group Company
The company is a listed company controlled by General Technology Group. Its predecessor was the China National Pharmaceutical and Health Products Import and Export Corporation established in 1983. It joined General Technology Group in 1999 and has now become the only pharmaceutical and medical device manufacturing and operation platform under the Group. The company's main business is pharmaceutical industry business, medical device business, and international trade business. The company's main products include Chinese herbal medicines, Chinese medicine tablets, traditional Chinese medicine extracts, proprietary Chinese medicines, health products, chemical preparations, chemical raw materials, diagnostic drugs and reagents, medical consumables, medical devices, specialty medical products, proprietary Chinese medicines, Chinese herbal medicines and tablets, formula granules, biological agents, nutritional health products, chemical raw materials and preparations, biological products, medical devices, diagnostic reagents, dressing consumables, Chinese herbal medicines, health food, etc. Corporate honors: In 2018, China Pharmaceutical won the “Listed Company China Innovative Enterprise Award”, “Listed Company with Outstanding Contribution to the 40th Anniversary of China's Reform and Opening-up”, “China's Most Valuable Listed Company Award”, “China's Top 100 Listed Companies Award”, “Listed Company Most Respected by Investors”, “Golden Junma Award for Listed Companies with the Most Craftsmanship”, “Listed Company 2018 Charity Action Award for Listed Companies”, and “2024 Chinese Healthcare Industry Green and Sustainable Practitioner”.
Company Profile
Company Executives
- Name
- Position
- Salary
- guang yang
- Chairman, Directors, Nomination Committee Members, Chairman of the Strategy and Investment Committee
- --
- yuandong liu
- Directors
- --
- chaoyin tong
- Directors, Member of the Strategy and Investment Committee
- --
- huidong hu
- Directors, General Manager, Member of the Strategy and Investment Committee
- 1.25M
- lingyun che
- Directors, Member of the Remuneration and Assessment Committee
- --
- zhiyong li
- Independent Directors, Member of the Strategy and Investment Committee, Chairman of the Remuneration and Assessment Committee
- 150.00K
- ruihua wang
- Independent Directors, Chairman of the Audit and Risk Control Committee, Member of the Remuneration and Assessment Committee, Nomination Committee Members
- --
- yonghong yan
- Independent Directors, Member of the Audit and Risk Control Committee, Chairman of the Nomination Committee
- 33.30K
- jinghua yuan
- Board Secretary
- 1.37M
- fan guo
- Securities Affairs Representative
- --
- yong qiang
- Chairman of the Supervisory Board, Auditors
- --
- zhiyong liu
- Auditors
- --
- yue wu
- Auditors
- --
- jiaqing hong
- Deputy General Manager
- 1.12M
- heping lv
- Assistant to the General Manager
- 795.40K
- huibo zhang
- Assistant to the General Manager
- 1.26M
- xiaohong ge
- Chief Financial Officer
- 482.10K
- xingbing zhou
- Member of the Audit and Risk Control Committee, Employee Directors, Member of the Strategy and Investment Committee
- 1.60M
- jian zhang
- General Counsel
- 1.06M
- shaofeng zhang
- Employee Supervisors
- --
- lin zhang
- Employee Supervisors
- 704.80K
Analysis
Price Target
No Data
No Data